Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vidar Fykse
Observed name:
V. Fykse
Institution:
St Olav's University Hospital
Observed institutions:
Norwegian University of Science and Technology,
St Olav's University Hospital
OpenAlex ID:
A5044490441
Treatment of ECL cell carcinoids with octreotide LAR
2004
·
V. Fykse
, A. K. Sandvik
, et al.
·
Scandinavian Journal of Gastroenterology
·
77
Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids
2010
·
Constantin S. Jianu
, Reidar Fossmark
, et al.
·
Scandinavian Journal of Gastroenterology
·
54
One-year follow-up study of patients with enterochromaffin-like cell carcinoids after treatment with octreotide long-acting release
2005
·
Vidar Fykse
, Arne Kristian Sandvik
, et al.
·
Scandinavian Journal of Gastroenterology
·
29
Somatostatin‐receptor 2 (sst2)‐mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomach
2005
·
Vidar Fykse
, David H Coy
, et al.
·
British Journal of Pharmacology
·
18
ECL cell histamine mobilization and parietal cell stimulation in the rat stomach studied by microdialysis and electron microscopy
2005
·
V. Fykse
, E. Solligård
, et al.
·
Acta Physiologica
·
15
Octreotide induces apoptosis in the oxyntic mucosa
2007
·
Sten Even Erlandsen
, Vidar Fykse
, et al.
·
Molecular and Cellular Endocrinology
·
8
Treatment of ECL cell carcinoids with octreotide LAR
2003
·
Vidar Fykse
, Ame K. Sandvik
, et al.
·
Gastroenterology
·
4
PDF
Hyperammonemi
2026
·
Stian Langen
, Vidar Fykse
, et al.
·
Tidsskrift for Den norske legeforening
PDF
Show more works
View as search
Works count:
8
Citation count:
205
H-index:
6
I10-index:
5
Year
Topic
Type